Serum amyloid a in clinical practice
Serum amyloid A (SAA) is an acute phase first class protein discovered a quarter of the century ago. Its concentration depends on clinical findings of the patient, illness activity and the therapy applied. SAA increases moderately to markedly (100-1000 mg/l) in bacterial and fungal infections, invas...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2004-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2004/0370-81790408267J.pdf |